The acute treatment of nerve agent exposure

Journal of the Neurological Sciences

Volumn 249, Issue 1, 2006, Pages 86-94

  Cannard, Kevin ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Acetylcholine esterase; Atropine; Nerve agent; Oxime; Sarin; Soman; Tabun; VX

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; CARBAMIC ACID; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; LORAZEPAM; MIDAZOLAM; MUSCARINIC RECEPTOR; NEOSTIGMINE; NERVE GAS; NICOTINIC RECEPTOR; OXIME; PHENTOLAMINE; PHYSOSTIGMINE; PRALIDOXIME; PYRIDOSTIGMINE;

APNEA; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; FASCICULATION; GAS POISONING; HUMAN; HYPERSALIVATION; MENTAL HEALTH; MIOSIS; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; OVERALL SURVIVAL; PARALYSIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEIZURE; WASTE MANAGEMENT;

ACETYLCHOLINESTERASE; ATROPINE; CHEMICAL TERRORISM; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; NEUROTOXICITY SYNDROMES; OXIMES; PHOSPHORIC ACID ESTERS; RECEPTORS, CHOLINERGIC; SYNAPTIC TRANSMISSION;

EID: 33750530352     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.008     Document Type: Article

References (37)

1. Trumpener U. The road to Ypres: the beginnings of gas warfare in World War I. J Mod Hist 47 3 (1975) 460-468
2. Sidell F., Takafuji E., and Franz D. Medical aspects of chemical and biological warfare (1997), Office of the Surgeon General United States Army at TMM Publications, Washington, D.C.
3. Macilwain C. Study proves Iraq used nerve gas. Nature 363 6424 (1993) 3
4. Newmark J. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology 62 9 (2004) 1590-1596
5. Kadivar H., and Adams S.C. Treatment of chemical and biological warfare injuries: insights derived from the 1984 Iraqi attack on Majnoon Island. Mil Med 156 4 (1991) 171-177
6. Council UNS. Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq (1984 (March 26)), United Nations, New York
7. Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., et al. Sarin poisoning in Matsumoto, Japan. Lancet 346 8970 (1995) 290-293
8. Ohbu S., Yamashina A., Takasu N., Yamaguchi T., Murai T., Nakano K., et al. Sarin poisoning on Tokyo subway. South Med J 90 6 (1997) 587-593
9. Okudera H. Clinical features on nerve gas terrorism in Matsumoto. J Clin Neurosci 9 1 (2002) 17-21
10. Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., et al. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 28 2 (1996) 129-135
11. United Nations. Centre for Disarmament Affairs. Disarmament: the chemical weapons convention with selective index (1994), United Nations, New York
12. Brennan R.J., Waeckerle J.F., Sharp T.W., and Lillibridge S.R. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med 34 2 (1999) 191-204
13. Craig F.N., Cummings E.G., and Sim V.M. Environmental temperature and the percutaneous absorption of a cholinesterase inhibitor, VX. J Invest Dermatol 68 6 (1977) 357-361
14. Cooper J.R., Bloom F.E., and Roth R.H. The biochemical basis of neuropharmacology. 8th ed. (2003), Oxford University Press, Oxford
15. Sidell F.R., and Groff W.A. The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol Appl Pharmacol 27 2 (1974) 241-252
16. Nozaki H., Hori S., Shinozawa Y., Fujishima S., Takuma K., Kimura H., et al. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med 23 9 (1997) 1005-1007
17. LeBlanc F.N., Benson B.E., and Gilg A.D. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol 24 1 (1986) 69-76
18. Goodman L.S., Hardman J.G., Limbird L.E., and Gilman A.G. Goodman and Gilman's the pharmacological basis of therapeutics. 10th/ed. (2001), McGraw-Hill, New York
19. Defense USAMRIoC. Nerve agents. Medical management of chemical casualties handbook. Third ed. (2000), USAMRICD, Chemical Casualty Care Division, Aberdeen Proving Ground, MD
20. Kawana N., Ishimatsu S., and Kanda K. Psycho-physiological effects of the terrorist sarin attack on the Tokyo subway system. Mil Med 166 12 Suppl. (2001) 23-26
21. Leikin J.B., Thomas R.G., Walter F.G., Klein R., and Meislin H.W. A review of nerve agent exposure for the critical care physician. Crit Care Med 30 10 (2002) 2346-2354
22. Sidell F.R. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 7 1 (1974) 1-17
23. Agency for Toxic Substances and Disease Registry A. Medical Management Guidelines (MMGs) for Nerve Agents: Tabun (GA; Sarin (GB); Soman; and VX. In: U.S. Dept. of Health and Human Services; 2006.
24. Marrs T.C., Maynard R.L., and Sidell F.R. Chemical warfare agents: toxicology and treatment (1996), Wiley, Chichester
25. Nozaki H., Hori S., Shinozawa Y., Fujishima S., Takuma K., Sagoh M., et al. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 21 12 (1995) 1032-1035
26. Woodall J. Tokyo subway gas attack. Lancet 350 9073 (1997) 296
27. Rotenberg J.S., and Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics 112 3 Pt 1 (2003) 648-658
28. Chyka P.A., Seger D., Krenzelok E.P., and Vale J.A. Position paper: single-dose activated charcoal. Clin Toxicol 43 2 (2005) 61-87
29. Vale J.A., Meredith T.J., and Heath A. High dose atropine in organophosphorus poisoning. Postgrad Med J 66 780 (1990) 878
30. Holstege C.P., Kirk M., and Sidell F.R. Chemical warfare. Nerve agent poisoning. Crit Care Clin 13 4 (1997) 923-942
31. Amitai Y., Almog S., Singer R., Hammer R., Bentur Y., and Danon Y.L. Atropine poisoning in children during the Persian Gulf crisis. A national survey in Israel. JAMA 268 5 (1992) 630-632
32. Tush G.M., and Anstead M.I. Pralidoxime continuous infusion in the treatment of organophosphate poisoning. Ann Pharmacother 31 4 (1997) 441-444
33. Thompson D.F. Pralidoxime chloride continuous infusions. Ann Emerg Med 16 7 (1987) 831-832
34. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40 6 (2002) 803-816
35. McDonough Jr. J.H., Zoeffel L.D., McMonagle J., Copeland T.L., Smith C.D., and Shih T.M. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38 1 (2000) 1-14
36. Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Minami M., and Omae K. Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environ Health Perspect 109 11 (2001) 1169-1173
37. Yokoyama K., Araki S., Murata K., Nishikitani M., Okumura T., Ishimatsu S., et al. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Arch Environ Health 53 4 (1998) 249-256